Proteomics International Laboratories Ltd (ASX:PIQ)
Australia · Delayed Price · Currency is AUD 0.1600
-0.0050 (-3.03%)
Aug 26, 2026, 2:48 PM AEST
ASX:PIQ Market Cap
ASX:PIQ has a market cap or net worth of 27.26 million as of August 26, 2026. Its market cap has decreased by -46.29% in one year.
Market Cap
27.26M
Enterprise Value
19.80M
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
ChartMarket Cap Chart
Since April 16, 2015, ASX:PIQ's market cap has increased from 11.39M to 27.26M, an increase of 139.40%. That is a compound annual growth rate of 7.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 27.26M | -74.59% |
| Dec 31, 2025 | 107.27M | 2.36% |
| Dec 31, 2024 | 104.80M | -4.28% |
| Dec 29, 2023 | 109.49M | -0.29% |
| Dec 30, 2022 | 109.81M | -14.46% |
| Dec 31, 2021 | 128.37M | 53.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nexsen | 47.05M |
| Neurizon Therapeutics | 45.73M |
| Radiopharm Theranostics | 43.38M |
| Imugene | 40.16M |
| Noxopharm | 28.27M |
| NeuroScientific Biopharmaceuticals | 25.33M |
| Argenica Therapeutics | 25.05M |
| EZZ Life Science Holdings | 22.36M |